Main Article Content

Authors

Objective. To validate in Colombia the abbreviated scale of representative symptoms of myeloproliferative neoplasms, for further use in research and for application in the clinical setting. Materials and methods. A cross-cultural adaptation of the MPN-SAF-TSS scale (myeloproliferative neoplasm symptom assessment form total symptom score) to Colombian Spanish using statistical validity and reliability analysis with a specific sample size for each psychometric property. Results. Based on the psychometric properties, the verification of reliability and internal structure with a Cronbach’s alpha scale of 0.8552 was achieved, denoting good internal consistency. A Lin’s concordance correlation coefficient of 0.765 was obtained, showing good reliability; factor analysis showed multiple correlation coefficient values above 0.3, indicating that the scale variables measure common factors. Concurrent validity determines that the scale measures what it should measure with an adequate Spearman correlation coefficient of -0.71 and -0.73 when confronted with the FACIT-Fatigue and Fact-Lym scales, respectively. Conclusion. The MPN-SAF-TSS scale adapted to Colombian Spanish is a valid assessment instrument for symptoms in patients with myeloproliferative neoplasms and can be used in clinical practice or trials due to its adequate psychometric properties.

Teófilo Lozano, CIIC Consultores SAS.

Msc, CIIC Consultores SAS.

Carolina Wiesner, CIIC Consultores SAS.

MD, CIIC Consultores SAS.

Rubén Mesa, Mayo Clinic Cancer Center.

MD, Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Scottsdale, Arizona, United States of America.

Marie Emanuel Robyn, Mayo Clinic Cancer Center.

MD, Division of Hematology & Medical Oncology, Mayo Clinic Cancer Center, Scottsdale, Arizona, United States of America.

Martha Suárez, CIIC Consultores SAS.

MD, CIIC Consultores SAS.

Edgar Salguero, CIIC Consultores SAS.

Msc, CIIC Consultores SAS.
Lozano, T., Wiesner, C., Mesa, R., Robyn, M. E., Suárez M., & Salguero, E. (2017). Validation of the Abbreviated Symptom Scale for Patients with Myeloproliferative Neoplasm (MPN-SAF-TSS): Evaluation for Colombian Patients. Revista Ciencias De La Salud, 15(3), 325–334. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.6116

Pardanani A, Gotlib JR, Jamieson C, Cortes JE, Talpaz M, Stone RM, et al. Safety and ef cacy of TG101348, a selective JAK2 inhibitor, in myelo brosis. J Clin Oncol. 2011 mar; 29(7):789-96.

Mesa RA, Kantarjian H, Tefferi A, Dueck A, Levy R, Vaddi K, et al. Evaluating the serial use of the Myelofibrosis Symptom Assessment Form for measuring symptomatic improvement: performance in

myelofibrosis patients on a jak1 and jak2 inhibitor (incb018424) clinical trial. Cancer. 2011nov; 117(21):4869-77.

Mesa RA, Niblack J, Wadleigh M, Verstovsek S, Camoriano J, Barnes S, et al. The burden of fatigue and quality of life in myeloproliferative disorders (mpds): An international Internet-based survey of 1179 mpd patients. Cancer. 2007 ene; 109(1):68-76.

Mesa RA, Schwager S, Radia D, Cheville A, Hussein K, Niblack J, et al. The Myelofibrosis Symptom Assessment Form MFSAF): An evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis. Leuk Res. 2009;33(9):1199-1203.

Scherber R, Dueck AC, Johansson P, Barbui T, Barosi G, Vannucchi AM, et al. The Myeloproliferative Neoplasm Symptom Assessment Form (mpn-saf): International prospective validation and reliability trial in 402 patients. Blood. 2011; 118(2):401-8.

Emanuel RM, Dueck AC, Geyer HL, Kiladjian J-J, Slot S, Zweegman S, et al. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: Prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNS. J Clin Oncol. 2012; 30(33):4098-103.

Emanuel RM, Dueck AC, Geyer HL, Kiladjian J-J, Slot S, Zweegman S, et. ál. Myeloproliferative (mpn) symptom burden response thresholds: Assessment of MNP-SAF-TSS quartiles as potential markers of symptom response. Blood. 2013;122(21):4067.

Montero I, León OG. Sistema de clasificación del método en los informes de investigación en Psicología 1. 2005;5:115-27.

R Core Team. R: A language and environment for statistical computing [internet]. 2014. R Foundation for Statistical Computing, Vienna, Austria. Disponible en: http://www.R-project.org/

Norman GR, Streiner DL. Bioestadística. Barcelona: Mosby Doyma Libros; 1996.

Donner A, Eliasziw M. Sample size requirements for reliability studies. Stat Med 1987;6:441-448.

Cohen RJ, Swerdlink ME. Pruebas y evaluación psicológicas. México: McGrawHill; 2001.

Lawrence I, Lin K. Aconcordance correlation coeficient to evaluate reproducibility. Biometrics. 1989 45(1):255-68.

Salkind NJ. Métodos de investigación. México: PrenticeHall; 1999.

Le B. La unidimensionalidad de un instrumento de medición: Perspectiva Factorial. 2005.

Mitra D, Kaye JA, Piecoro LT, Brown J, Reith K, Mughal TI, et al. Symptom burden and splenomegaly in patients with myelofibrosis in the United States: A retrospective medical record review. Cancer Med. 2013;2(6):889-98.

Downloads

Download data is not yet available.

Most read articles by the same author(s)